Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Operating Income Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn -37.93%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn -9.81%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.81%
Mar 31, 2026 15.57%
Dec 31, 2025 46.27%
Sep 30, 2025 70.13%
Jun 30, 2025 27.75%
Mar 31, 2025 17.95%
Dec 31, 2024 -70.74%
Sep 30, 2024 7.78%
Jun 30, 2024 11.81%
Mar 31, 2024 22.20%
Dec 31, 2023 161.32%
Sep 30, 2023 56.95%
Jun 30, 2023 355.66%
Mar 31, 2023 190.32%
Dec 31, 2022 1,011.99%
Sep 30, 2022 174.37%
Jun 30, 2022 -52.17%
Mar 31, 2022 -53.67%
Dec 31, 2021 -119.64%
Sep 30, 2021 -242.95%